You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
智飛生物(300122.SZ)業績快報:2020年度淨利潤升39.47%至33億元
格隆匯 02-21 16:59

格隆匯 2 月 21日丨智飛生物(300122.SZ)披露2020年度業績快報,實現營業總收入151.9億元,同比增長43.48%;營業利潤38.94億元,同比增長38.40%;利潤總額38.53億元,同比增長39.33%;歸屬於上市公司股東的淨利潤33億元,同比增長39.47%;基本每股收益2.0628元。

2020年度,新型冠狀病毒感染肺炎疫情爆發流運輸效率、人員流動情況、預防接種門診工作開展等較去年同期相比發生了較大變化。儘管受新冠疫情不利影響,公司積極投身抗疫工作,穩步推動復工復產,努力做好研產銷等經營管理工作,在公司管理層的帶領下踐行年度經營計劃,持續專注疫苗及生物製品研發、生產、銷售、推廣、配送及進口疫苗代理等,卓有成效,各項業務發展勢頭良好,疫苗產品銷售穩定增長,推動公司業績穩步提升,公司主營業務收入、淨利潤等重要財務指標較上年同期均有較好的增長。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account